Header cover image

U.S. Clinical Research and Equipment Industry Analysis

UpdatedJul 25, 2024
DataAggregated Company Financials
Companies62
  • 7D2.3%
  • 3M1.4%
  • 1Y-4.3%
  • YTDn/a

Last week, the Clinical Research and Equipment industry hasn't moved much but Thermo Fisher Scientific is up 3.5% in that time. As for the longer term, the industry has declined 4.8% in the last year. As for the next few years, earnings are expected to grow by 15% per annum.

Industry Valuation and Performance

Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Jul 2024US$695.7bUS$141.1bUS$12.3b40.2x56.6x4.9x
Sat, 22 Jun 2024US$684.7bUS$141.3bUS$12.2b38.6x56.2x4.8x
Mon, 20 May 2024US$741.1bUS$141.5bUS$12.4b38.2x59.6x5.2x
Wed, 17 Apr 2024US$703.0bUS$142.0bUS$12.8b42.2x55x4.9x
Fri, 15 Mar 2024US$753.0bUS$142.1bUS$12.8b44.6x58.7x5.3x
Sun, 11 Feb 2024US$708.4bUS$141.9bUS$12.7b39.7x55.7x5x
Tue, 09 Jan 2024US$684.7bUS$153.9bUS$14.2b37x48.3x4.5x
Thu, 07 Dec 2023US$648.0bUS$153.7bUS$14.0b35.3x46.3x4.2x
Sat, 04 Nov 2023US$597.3bUS$153.9bUS$11.0b31.5x54.2x3.9x
Mon, 02 Oct 2023US$672.6bUS$154.6bUS$11.2b33.3x60x4.4x
Wed, 30 Aug 2023US$733.4bUS$154.6bUS$11.2b33.4x65.4x4.7x
Fri, 28 Jul 2023US$751.7bUS$154.7bUS$11.8b30.4x63.7x4.9x
Sun, 25 Jun 2023US$690.9bUS$152.4bUS$12.5b29.3x55.3x4.5x
Tue, 23 May 2023US$689.0bUS$152.1bUS$12.5b29x55.2x4.5x
Thu, 20 Apr 2023US$736.5bUS$154.6bUS$10.8b30.2x68.2x4.8x
Sat, 18 Mar 2023US$701.0bUS$154.5bUS$10.8b27.3x64.8x4.5x
Mon, 13 Feb 2023US$745.6bUS$155.6bUS$8.7b30.6x85.6x4.8x
Wed, 11 Jan 2023US$743.5bUS$155.2bUS$8.8b29.9x84.7x4.8x
Fri, 09 Dec 2022US$772.3bUS$155.1bUS$8.8b29x88x5x
Sun, 06 Nov 2022US$706.9bUS$154.9bUS$9.1b25.8x78x4.6x
Tue, 04 Oct 2022US$722.6bUS$152.5bUS$17.0b23.8x42.5x4.7x
Thu, 01 Sep 2022US$759.4bUS$152.3bUS$17.3b29x43.9x5x
Sat, 30 Jul 2022US$834.2bUS$151.6bUS$18.2b33.5x45.7x5.5x
Mon, 27 Jun 2022US$731.0bUS$148.1bUS$20.1b30.5x36.4x4.9x
Wed, 25 May 2022US$730.6bUS$148.0bUS$20.0b30.5x36.4x4.9x
Fri, 22 Apr 2022US$838.6bUS$146.5bUS$25.3b34.8x33.1x5.7x
Sun, 20 Mar 2022US$874.0bUS$145.3bUS$25.1b37x34.8x6x
Tue, 15 Feb 2022US$856.1bUS$143.8bUS$24.9b38.8x34.4x6x
Thu, 13 Jan 2022US$921.4bUS$138.0bUS$27.3b42.2x33.7x6.7x
Sat, 11 Dec 2021US$959.4bUS$138.0bUS$27.3b43.1x35.1x7x
Mon, 08 Nov 2021US$950.5bUS$137.6bUS$27.2b45.9x35x6.9x
Wed, 06 Oct 2021US$701.2bUS$105.9bUS$18.6b46.2x37.6x6.6x
Fri, 03 Sep 2021US$754.2bUS$105.8bUS$18.7b52x40.4x7.1x
Sun, 01 Aug 2021US$707.4bUS$105.8bUS$18.7b43.3x37.9x6.7x
Price to Earnings Ratio

37.9x


Total Market Cap: US$707.4bTotal Earnings: US$18.7bTotal Revenue: US$105.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Clinical Research and Equipment Industry Price to Earnings3Y Average 51.7x202220232024
Current Industry PE
  • Investors are optimistic on the American Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 56.1x which is higher than its 3-year average PE of 51.7x.
  • The industry is trading close to its 3-year average PS ratio of 5.2x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 13% per year over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Clinical Research and Equipment compare with similar industries?

US Market-2.91%
Healthcare-0.66%
Life Sciences2.28%
Clinical Research and Equipment2.28%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TMO Thermo Fisher ScientificUS$574.733.5%
+US$7.5b
0.06%PE36.4x
DHR DanaherUS$265.765.8%
+US$5.8b
0.3%PE47.3x
IQV IQVIA HoldingsUS$238.753.7%
+US$1.6b
2.9%PE30.6x
AVTR AvantorUS$22.374.4%
+US$645.3m
-4.1%PE58.4x
A Agilent TechnologiesUS$134.160.5%
+US$192.6m
4.4%PE31.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AZTA

US$56.99

Azenta

7D

3.1%

1Y

20.4%

WST

US$323.77

West Pharmaceutical Services

7D

-1.0%

1Y

-14.7%

DHR

US$265.76

Danaher

7D

5.8%

1Y

0.3%

ICLR

US$331.77

ICON

7D

-0.6%

1Y

31.1%

TMO

US$574.73

Thermo Fisher Scientific

7D

3.5%

1Y

0.06%

IQV

US$238.75

IQVIA Holdings

7D

3.7%

1Y

2.9%

MEDP

US$381.88

Medpace Holdings

7D

-12.6%

1Y

48.9%

WAT

US$305.31

Waters

7D

-2.9%

1Y

5.3%

A

US$134.16

Agilent Technologies

7D

0.5%

1Y

4.4%

TEM

US$38.05

Tempus AI

7D

-4.5%

1Y

n/a

TKNO

US$3.27

Alpha Teknova

7D

70.3%

1Y

-3.5%

MTD

US$1,384.56

Mettler-Toledo International

7D

0.5%

1Y

3.7%